H.C. Wainwright Reiterates Neutral Rating on Traws Pharma Inc. (TRAW)
Tweet Send to a Friend
H.C. Wainwright analyst Brandon Folkes reiterated a Neutral rating and $1.00 price target on Traws Pharma Inc. (NASDAQ: TRAW).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
